Table 1.

Classical factors associated with new vascular events at one-year follow-up

	Primary end-point
	Yes (n = 78)	No (n = 485)	p
Male, %	77.6	67.0	0.15
Age	72.6 (8.4)	71.1 (7.2)	0.31
Weight	78.8 (14.3)	74.8 (12.1)	0.01
Height	165.4 (7.5)	164.0 (8.0)	0.17
Body mass index	28.8 (4.7)	27.8 (4.3)	0.09
Waist circumference	101.0 (14.9)	100.1 (12.9)	0.22
Systolic blood pressure	162.4 (25.4)	152.4 (26.5)	0.06
Diastolic blood pressure	85.2 (13.3)	82.3 (13.5)	0.10
Familiar history of cardiovascular disease
Stroke, %	23.1	18.1	0.52
Ischaemic CHD, %	11.5	16.3	0.31
Sudden death, %	5.1	3.3	0.50
Personal history
Alcohol intake, % (>40gr/day)	10.4	5.0	0.07
Active smoker, %	18.4	18.1	0.81
Arterial hypertension, %	72.4	71.6	0.87
Diabetes mellitus, %	51.3	32.2	0.002
Dyslipidaemia, %	51.9	43.9	0.22
Ischaemic CHD, %	16.9	11.4	0.18
Symptomatic PAD, %	18.2	7.6	0.005
Treatment before index stroke
Antiplatelet agents, %	29.5	24.7	0.39
Statins, %	33.3	26.8	0.49
Antihypertensive, %	61.5	60.4	0.62
Hypoglycaemics, %	41.0	25.4	0.01
Treatment at discharge
Antiplatelet agents	100	99.3	0.46
Statins	70.0	71.8	0.84
Antihypertensive drugs	75.6	72.8	0.65
Hypoglycaemics	42.8	31.5	0.05
Stroke subtype			0.07
Atherothrombotic
Probable	25.0	15.7
Possible	46.1	43.0
Small vessel disease	18.4	21.0
Cryptogenic	10.5	20.3
mRankin <2 at discharge	41.0	57.9	0.08
mRankin ≤2 at 1 year	39.0	70.3	<0.0001

CHD: cardiac heart disease. PAD: peripheral artery disease.

P-value (log-rank test).